About Aurigene
Aurigene is a company based in Bengaluru (India) founded in 2001. It operates as a B2B and Partnerships. The company has 479 employees as of March 31, 2023. Aurigene offers products and services including Drug Discovery Platform and Clinical Pipeline. Aurigene operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Bengaluru, India
- Employees 479 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aurigene Oncology Limited
- Date of Incorporation 10 Aug, 2001
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$35.09 M (USD)-5.65as on Mar 31, 2023
-
Net Profit
$4.17 M (USD)-49.64as on Mar 31, 2023
-
EBITDA
$4.87 M (USD)-51.84as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
479
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurigene
Aurigene offers a comprehensive portfolio of products and services, including Drug Discovery Platform and Clinical Pipeline.
Platform for developing novel cancer therapeutics through research
Pipeline of drugs in trials for oncology treatment and partnerships
People of Aurigene
Unlock access to complete
Unlock access to complete
Funding Insights of Aurigene
Detailed funding history for Aurigene
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aurigene
Investment portfolio details for Aurigene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aurigene
Detailed financials for Aurigene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurigene Comparisons
Peer comparison for Aurigene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aurigene
Aurigene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Aurigene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurigene
Complete news archive for Aurigene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurigene
Aurigene was founded in 2001.
Aurigene is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Mar 31, 2023, the latest employee count at Aurigene is 479.
Annual revenue of Aurigene is $35.09M as on Mar 31, 2023.
Aurigene Oncology, founded in 2001, is a clinical stage biotech company based in Bangalore, India, focused on discovering and developing innovative therapeutics for cancer treatment. It leverages advanced science and global partnerships to build a robust pipeline of drugs. The company conducts integrated drug discovery projects and collaborates with international entities to advance oncology solutions for patients worldwide.
Aurigene's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Aurigene offers Drug Discovery Platform and Clinical Pipeline.